Advisors Asset Management Inc. Increases Holdings in DENTSPLY SIRONA Inc. $XRAY

Key Points

• Advisors Asset Management Inc. increased its stake in DENTSPLY SIRONA by 507.8% during the first quarter, now owning approximately 104,272 shares worth $1.56 million.
• DENTSPLY SIRONA recently announced a quarterly dividend of $0.16, representing a 4.6% yield, payable on October 10th.
• Analysts have generally rated DENTSPLY SIRONA as a Hold, with a consensus price target of $18.64.

Advisors Asset Management Inc. boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 507.8% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 104,272 shares of the medical instruments supplier's stock after buying an additional 87,115 shares during the period. Advisors Asset Management Inc. owned approximately 0.05% of DENTSPLY SIRONA worth $1,558,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. boosted its stake in DENTSPLY SIRONA by 9.0% during the first quarter. Envestnet Asset Management Inc. now owns 494,737 shares of the medical instruments supplier's stock valued at $7,391,000 after buying an additional 40,936 shares during the period. Brown Advisory Inc. bought a new stake in DENTSPLY SIRONA during the first quarter valued at $679,000. Wealth Enhancement Advisory Services LLC boosted its stake in DENTSPLY SIRONA by 39.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 53,903 shares of the medical instruments supplier's stock valued at $805,000 after buying an additional 15,117 shares during the period. GAMMA Investing LLC boosted its stake in DENTSPLY SIRONA by 1,462.9% during the first quarter. GAMMA Investing LLC now owns 99,351 shares of the medical instruments supplier's stock valued at $1,484,000 after buying an additional 92,994 shares during the period. Finally, Captrust Financial Advisors boosted its stake in DENTSPLY SIRONA by 39.0% during the fourth quarter. Captrust Financial Advisors now owns 23,548 shares of the medical instruments supplier's stock valued at $447,000 after buying an additional 6,609 shares during the period. Institutional investors own 95.70% of the company's stock.

Analysts Set New Price Targets

Several brokerages have issued reports on XRAY. Wall Street Zen lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Wells Fargo & Company dropped their price target on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a research note on Friday, August 8th. UBS Group dropped their price target on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Barrington Research dropped their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a research note on Friday, August 8th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Two analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $18.64.

DENTSPLY SIRONA Trading Down 2.9%

Shares of NASDAQ XRAY traded down $0.41 during midday trading on Friday, reaching $13.53. The company had a trading volume of 3,721,038 shares, compared to its average volume of 2,536,210. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $27.48. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The firm's fifty day moving average price is $14.73 and its 200-day moving average price is $15.02. The stock has a market cap of $2.70 billion, a PE ratio of -2.85, a price-to-earnings-growth ratio of 0.87 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The company had revenue of $936.00 million during the quarter, compared to analyst estimates of $929.67 million. During the same quarter in the previous year, the company posted $0.49 EPS. DENTSPLY SIRONA's revenue for the quarter was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA's payout ratio is currently -13.50%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.